Cargando…
Inhibiting miR-182-3p Alleviates Gestational Diabetes Mellitus by Improving Insulin Resistance in Skeletal Muscle
BACKGROUND: Gestational diabetes mellitus (GDM) is one of the most common metabolic diseases occurring during pregnancy. MiR-182-3p participates in a variety of physiological processes such as cell proliferation, apoptosis, differentiation, and migration5, but its role in GDM is largely unknown. AIM...
Autores principales: | Rao, Jinghong, Chen, Youfang, Huang, Jingying, Wu, Ruoying, Dong, Zhenzhu, Gao, Yuling, Chen, Xuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Galenos Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8941230/ https://www.ncbi.nlm.nih.gov/pubmed/35330559 http://dx.doi.org/10.4274/balkanmedj.galenos.2021.2021-8-140 |
Ejemplares similares
-
Inhibition of miR-182-5p Targets FGF9 to Alleviate Osteoarthritis
por: Sun, Yang, et al.
Publicado: (2023) -
Role of miR-182 in cardiovascular and cerebrovascular diseases
por: Pei, Gaiqin, et al.
Publicado: (2023) -
SIRT1 alleviates hepatic ischemia-reperfusion injury via the miR-182-mediated XBP1/NLRP3 pathway
por: Li, Fengwei, et al.
Publicado: (2020) -
Circulating miR-30a-5p and miR-182-5p in Prediabetes and Screen-Detected Diabetes Mellitus
por: Weale, Cecil Jack, et al.
Publicado: (2020) -
Roles of miR-182 in sensory organ development and cancer
por: Wei, Qing, et al.
Publicado: (2015)